The alteration in LCK localisation in addition to the reduced levels of pZAP70 in T-ALL cells with UNC119 inhibition resulted in a dose-dependent reduction in cell proliferation in all three cell lines (Fig 4E), with the most pronounced effect observed in CCRF T-ALL cells. Here, BID is linked to acute lymphoblastic leukemia.